SCPH: scPharmaceuticals Inc

SCPH新闻

• 21:34 MannKind以2.965亿美元完成对scPharmaceuticals的收购
• 21:34 MannKind completes acquisition of scPharmaceuticals in $296.5 million deal
• 13:26 MannKind完成对scPharmaceuticals的收购；SCPH将从纳斯达克退市
• 11:30 MannKind stock price target raised to $11 by H.C. Wainwright on Tyvaso success
• 11:41 MannKind to acquire scPharmaceuticals stock in $303 million deal, H.C. Wainwright downgrades
• 10:07 MannKind stock price target raised to $8 by RBC on scPharmaceuticals deal
• 17:57 MannKind, Backed By Blackstone, Expands Cardiorenal Focus With $360 Million Deal - MannKind (NASDAQ:MNKD), scPharmaceuticals (NASDAQ:SCPH)
• 13:32 MannKind stock falls after announcing acquisition of scPharmaceuticals
• 11:35 MannKind to acquire scPharmaceuticals for up to $6.35 per share
• 10:14 scPharmaceuticals amends supply agreement with West Pharmaceutical Services
• 12:44 scPharmaceuticals receives five patent allowances for furosemide formulation
• 22:00 scPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Lags Revenue Estimates
• 00:20 Cytek Biosciences, Inc. (CTKB) Beats Q2 Earnings Estimates
• 12:13 scPharmaceuticals (SCPH) Soars 8.8%: Is Further Upside Left in the Stock?
• 15:15 SC Pharmaceuticals at H.C. Wainwright: Furosex’s Strategic Expansion
• 21:36 scPharmaceuticals Inc. Reports First Quarter 2025 Financial Results and Provides Business Update
• 20:53 Scpharmaceuticals earnings missed by $0.04, revenue fell short of estimates
• 23:13 scPharmaceuticals Inc. (SCPH) Q4 2024 Earnings Call Transcript